Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Indian tycoon's extradition hearing told of abuse of UK 'Chennai Six'

Published 14/12/2017, 16:23
© Reuters. Indian tycoon Vijay Mallya is seen outside Westminster Magistrates Court in London
KGF
-

LONDON (Reuters) - One of the "Chennai Six" group of ex-British soldiers jailed in India was dragged to a psychiatric hospital and force-fed anti-psychotic tablets during his time in jail, a London court considering whether to extradite Indian tycoon Vijay Mallya was told on Thursday.

Mallya, 61, is wanted in India on fraud and money-laundering charges relating to his defunct Kingfisher (LON:KGF) Airlines and Indian authorities want to recover about $1.4 billion (£1 billion) they say Kingfisher owes.

The businessman, co-owner of the Force India Formula One team, who moved to Britain in March last year, says the case him is politically motivated and is fighting extradition on several grounds including a claim that jail conditions in India are incompatible with British human rights laws.

As part of this, his lawyer quizzed prison conditions expert Dr Alan Mitchell about a conversation he had had two days ago with one of the former British soldiers who had been held for four years in India on weapons-smuggling charges after the vessel they were working on strayed into Indian waters in 2013.

The soldiers were released from jail in Chennai, eastern India, after a successful appeal and began arriving back in Britain last week.

The ex-soldier, named only as "A", said he had been grabbed by 15 prison guards and prisoners and taken to a psychiatric hospital because he had been "excessively walking" around the prison, Mitchell told London's Westminster Magistrate Court.

"While in the psychiatric hospital, he stated he was tied up, gagged, he was beaten and he was forcibly injected. In addition he described being force-fed anti-psychotic tablets that he managed to spit out," Mitchell said.

Asked by Mallya's lawyer Clare Montgomery about assurances given over the treatment of Mallya, who she said had diabetes, coronary artery disease and sleep apnoea, Mitchell said the British government had likewise told parliament that the Chennai Six were being well looked after.

"Despite assurances having been given in parliament, 'A' was extremely disappointed by what effect the involvement of the High Commission and the UK government had on conditions in which he and his fellow prisoners were held," he said.

Mark Summers, the lawyer representing the Indian government, said Mitchell's evidence involved an uncorroborated account which could be used as a "platform for a compensation claim against the UK government".

He said conditions in Chennai would bear no relation to the jail in Mumbai where Mallya would be held.

© Reuters. Indian tycoon Vijay Mallya is seen outside Westminster Magistrates Court in London

Another hearing in the London extradition case against Mallya will be held on Jan. 10 with a decision expected at a later date.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.